UTS2B
gene geneOn this page
Also known as URPU2B
Summary
UTS2B (urotensin 2B, HGNC:30894) is a protein-coding gene on chromosome 3q28, encoding Urotensin-2B (Q765I0). Potent vasoconstrictor.
Predicted to enable G protein-coupled receptor binding activity. Predicted to be involved in regulation of blood pressure. Predicted to be located in extracellular region.
Source: NCBI Gene 257313 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 21 total
- MANE Select transcript:
NM_198152
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30894 |
| Approved symbol | UTS2B |
| Name | urotensin 2B |
| Location | 3q28 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | URP, U2B |
| Ensembl gene | ENSG00000188958 |
| Ensembl biotype | protein_coding |
| OMIM | 618134 |
| Entrez | 257313 |
Gene structure
Transcript identifiers
Ensembl transcripts: 11 — 5 protein_coding, 3 nonsense_mediated_decay, 2 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000340524, ENST00000425357, ENST00000427544, ENST00000432514, ENST00000440476, ENST00000446788, ENST00000463450, ENST00000464814, ENST00000490825, ENST00000899455, ENST00000915518
RefSeq mRNA: 1 — MANE Select: NM_198152
NM_198152
CCDS: CCDS3300
Canonical transcript exons
ENST00000340524 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001369529 | 191267168 | 191268441 |
| ENSE00001383373 | 191276807 | 191276844 |
| ENSE00001512014 | 191304492 | 191304548 |
| ENSE00001512015 | 191316036 | 191316439 |
| ENSE00001512016 | 191328631 | 191328709 |
| ENSE00001512017 | 191330414 | 191330526 |
| ENSE00003531376 | 191278072 | 191278170 |
| ENSE00003664443 | 191282087 | 191282313 |
| ENSE00003687596 | 191275252 | 191275345 |
Expression profiles
Bgee: expression breadth ubiquitous, 146 present calls, max score 82.43.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.3131 / max 230.7094, expressed in 24 samples.
FANTOM5 promoters (8 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 46106 | 0.1723 | 17 |
| 46107 | 0.0969 | 18 |
| 46105 | 0.0216 | 4 |
| 46108 | 0.0097 | 2 |
| 46101 | 0.0041 | 1 |
| 46104 | 0.0039 | 2 |
| 46102 | 0.0028 | 1 |
| 46103 | 0.0018 | 1 |
Top tissues by expression
238 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.43 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 80.83 | gold quality |
| secondary oocyte | CL:0000655 | 69.78 | gold quality |
| left testis | UBERON:0004533 | 68.59 | gold quality |
| right testis | UBERON:0004534 | 67.64 | gold quality |
| testis | UBERON:0000473 | 67.44 | gold quality |
| stromal cell of endometrium | CL:0002255 | 65.96 | gold quality |
| buccal mucosa cell | CL:0002336 | 60.78 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 60.77 | gold quality |
| right uterine tube | UBERON:0001302 | 59.73 | gold quality |
| right lobe of liver | UBERON:0001114 | 59.70 | gold quality |
| vermiform appendix | UBERON:0001154 | 58.07 | gold quality |
| colonic epithelium | UBERON:0000397 | 57.66 | silver quality |
| liver | UBERON:0002107 | 57.40 | gold quality |
| gall bladder | UBERON:0002110 | 57.28 | gold quality |
| calcaneal tendon | UBERON:0003701 | 56.80 | gold quality |
| bone marrow cell | CL:0002092 | 56.31 | gold quality |
| right coronary artery | UBERON:0001625 | 56.03 | gold quality |
| rectum | UBERON:0001052 | 55.88 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 55.25 | gold quality |
| left ovary | UBERON:0002119 | 54.97 | gold quality |
| cortical plate | UBERON:0005343 | 54.77 | gold quality |
| lymph node | UBERON:0000029 | 54.61 | gold quality |
| caecum | UBERON:0001153 | 54.13 | gold quality |
| small intestine | UBERON:0002108 | 53.91 | gold quality |
| amygdala | UBERON:0001876 | 53.79 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 53.49 | gold quality |
| omental fat pad | UBERON:0010414 | 53.46 | gold quality |
| upper leg skin | UBERON:0004262 | 53.45 | silver quality |
| peritoneum | UBERON:0002358 | 53.43 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-112 | yes | 8000.07 |
| E-ANND-3 | no | 4.34 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
83 targeting UTS2B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-6798-5P | 100.00 | 65.77 | 699 |
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-4803 | 99.98 | 71.99 | 3117 |
| HSA-LET-7F-2-3P | 99.98 | 70.98 | 2588 |
| HSA-MIR-1185-1-3P | 99.98 | 71.04 | 2593 |
| HSA-MIR-1185-2-3P | 99.98 | 71.04 | 2593 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-302C-5P | 99.97 | 72.56 | 3642 |
| HSA-MIR-7152-3P | 99.97 | 67.47 | 849 |
| HSA-MIR-4666A-3P | 99.96 | 71.71 | 3434 |
| HSA-MIR-101-3P | 99.94 | 75.03 | 2230 |
| HSA-MIR-144-3P | 99.94 | 73.98 | 2698 |
| HSA-MIR-9983-3P | 99.94 | 71.48 | 3631 |
| HSA-MIR-338-5P | 99.92 | 72.34 | 2951 |
| HSA-MIR-652-5P | 99.91 | 67.49 | 505 |
| HSA-MIR-1305 | 99.91 | 71.43 | 3443 |
| HSA-MIR-8062 | 99.88 | 68.43 | 995 |
| HSA-MIR-4698 | 99.84 | 71.41 | 4303 |
| HSA-MIR-4307 | 99.82 | 70.45 | 3374 |
| HSA-MIR-3680-3P | 99.75 | 72.51 | 3095 |
| HSA-MIR-33A-3P | 99.70 | 70.27 | 3362 |
| HSA-MIR-1283 | 99.69 | 72.42 | 3009 |
| HSA-MIR-519A-3P | 99.67 | 71.67 | 1868 |
| HSA-MIR-519B-3P | 99.67 | 71.67 | 1868 |
| HSA-MIR-519C-3P | 99.67 | 71.67 | 1870 |
| HSA-MIR-587 | 99.64 | 70.86 | 2611 |
| HSA-MIR-567 | 99.63 | 68.57 | 1219 |
Literature-anchored findings (GeneRIF, showing 7)
- URP could possibly be the endogenous and functional ligand for the human UII receptor (PMID:14550283)
- These findings suggest that U-II plays key roles in accelerating the development of atherosclerosis, thereby leading to coronary artery disease. (PMID:16940699)
- Urotensin II gene may contribute to the genetic susceptibility to gestational diabetes mellitus in Chinese population (PMID:17327028)
- Elevated serum urotensin II is associated with chronic liver disease and portal hypertension (PMID:17919235)
- vascular remodelling processes in conjunction with enhanced vasoconstriction are involved in the pathogenesis of pulmonary hypertension; UII may play a novel role in the pathogenesis of this disorder (PMID:18000598)
- U2B’’ has a relaxed specificity for its RNA targets. (PMID:21684671)
- family-based analysis of association between blood pressure, glomerular filtration and genes of the urotensin-II pathway (urotensin-II, urotensin-II related peptide, urotensin-II receptor) saturated with 28 tagging single nucleotide polymorphisms (PMID:24391740)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Uts2b | ENSMUSG00000056423 |
| rattus_norvegicus | Uts2b | ENSRNOG00000038512 |
Protein
Protein identifiers
Urotensin-2B — Q765I0 (reviewed: Q765I0)
Alternative names: Urotensin II-related peptide, Urotensin IIB, Urotensin-2 domain-containing protein
All UniProt accessions (4): C9JU87, F2Z3I1, F8WCV4, Q765I0
UniProt curated annotations — full annotation on UniProt →
Function. Potent vasoconstrictor.
Subcellular location. Secreted.
Similarity. Belongs to the urotensin-2 family.
RefSeq proteins (1): NP_937795* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001483 | Urotensin_II | Conserved_site |
| IPR043255 | U-IIB | Family |
UniProt features (5 total): signal peptide 1, propeptide 1, peptide 1, disulfide bond 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q765I0-F1 | 66.82 | 0.06 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 113–118
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-375276 | Peptide ligand-binding receptors |
| R-HSA-416476 | G alpha (q) signalling events |
MSigDB gene sets: 60 (showing top):
GOBP_REGULATION_OF_BLOOD_PRESSURE, GOBP_CIRCULATORY_SYSTEM_PROCESS, GOBP_REGULATION_OF_ANATOMICAL_STRUCTURE_SIZE, REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS, GOMF_G_PROTEIN_COUPLED_RECEPTOR_BINDING, GOMF_SIGNALING_RECEPTOR_BINDING, GOBP_VASCULAR_PROCESS_IN_CIRCULATORY_SYSTEM, GOMF_HORMONE_ACTIVITY, REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS, REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS, GOMF_SIGNALING_RECEPTOR_REGULATOR_ACTIVITY, GOBP_REGULATION_OF_TUBE_SIZE, GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_IL2_CULTURE_DN, E2F2_TARGET_GENES, LHX9_TARGET_GENES
GO Biological Process (3): regulation of blood pressure (GO:0008217), blood vessel diameter maintenance (GO:0097746), signal transduction (GO:0007165)
GO Molecular Function (2): G protein-coupled receptor binding (GO:0001664), hormone activity (GO:0005179)
GO Cellular Component (1): extracellular region (GO:0005576)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Class A/1 (Rhodopsin-like receptors) | 1 |
| GPCR downstream signalling | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| blood circulation | 2 |
| regulation of biological quality | 1 |
| vascular process in circulatory system | 1 |
| regulation of tube diameter | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| signaling receptor binding | 1 |
| receptor ligand activity | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
512 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| UTS2B | UTS2R | Q9UKP6 | 868 |
| UTS2B | UTS2 | O95399 | 833 |
| UTS2B | SSTR2 | P30874 | 512 |
| UTS2B | GNG4 | P50150 | 472 |
| UTS2B | OSTN | P61366 | 461 |
| UTS2B | ARHGAP36 | Q6ZRI8 | 459 |
| UTS2B | FREM3 | P0C091 | 456 |
| UTS2B | HTR1B | P28222 | 455 |
| UTS2B | VWC2 | Q2TAL6 | 447 |
| UTS2B | ACTN2 | P35609 | 446 |
| UTS2B | RAB11FIP4 | Q86YS3 | 442 |
| UTS2B | TMC3 | Q7Z5M5 | 436 |
| UTS2B | CCL19 | Q99731 | 434 |
| UTS2B | CORT | O00230 | 433 |
| UTS2B | ZNF784 | Q8NCA9 | 417 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| UTS2B | RPN1 | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (2): UTS2R (Reconstituted Complex), UTS2B (Proximity Label-MS)
ESM2 similar proteins: A8WU84, C0HKT1, C0HKT3, C0HKU2, D2IT41, D2Z1D6, E2A3M7, E2A6Z3, E2AJ76, E2AX75, E2AZE8, E2E4L2, O96690, P05110, P09929, P0DQY8, P18145, P28672, P28673, P28674, P33715, P61849, P61855, P80111, P85527, P85798, P86442, Q11099, Q18184, Q18234, Q18502, Q27441, Q29B55, Q75UG5, Q765I0, Q76CL2, Q7Q7R8, Q868F8, Q8T112, Q8WRC7
Diamond homologs: Q765I0, Q765I1, Q765I2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
21 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 11 |
| Likely benign | 4 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1593 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:191329719:GGAAG:G | donor_gain | 1.0000 |
| 3:191329720:G:GT | donor_gain | 1.0000 |
| 3:191329721:A:T | donor_gain | 1.0000 |
| 3:191329722:AGGT:A | donor_loss | 1.0000 |
| 3:191329723:GGTAA:G | donor_loss | 1.0000 |
| 3:191329724:G:C | donor_loss | 1.0000 |
| 3:191329725:T:G | donor_loss | 1.0000 |
| 3:191275355:T:TC | acceptor_gain | 0.9900 |
| 3:191277428:T:TA | donor_gain | 0.9900 |
| 3:191329720:GAAG:G | donor_gain | 0.9900 |
| 3:191329724:G:GG | donor_gain | 0.9900 |
| 3:191276865:A:C | acceptor_gain | 0.9800 |
| 3:191277425:A:AC | donor_gain | 0.9800 |
| 3:191277426:C:CC | donor_gain | 0.9800 |
| 3:191275346:C:CC | acceptor_gain | 0.9700 |
| 3:191329376:A:AC | donor_gain | 0.9700 |
| 3:191329377:C:CC | donor_gain | 0.9700 |
| 3:191330410:TGACC:T | donor_loss | 0.9700 |
| 3:191330411:GACCT:G | donor_loss | 0.9700 |
| 3:191330412:ACCTG:A | donor_loss | 0.9700 |
| 3:191330413:CCT:C | donor_loss | 0.9700 |
| 3:191330413:CCTGG:C | donor_gain | 0.9700 |
| 3:191275349:A:C | acceptor_gain | 0.9600 |
| 3:191275342:CCAG:C | acceptor_gain | 0.9500 |
| 3:191275343:CAG:C | acceptor_gain | 0.9500 |
| 3:191275343:CAGC:C | acceptor_gain | 0.9500 |
| 3:191275355:T:C | acceptor_gain | 0.9500 |
| 3:191329722:AG:A | donor_gain | 0.9500 |
| 3:191329723:GG:G | donor_gain | 0.9500 |
| 3:191330449:C:A | donor_gain | 0.9500 |
AlphaMissense
768 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:191268431:C:A | W115C | 0.990 |
| 3:191268431:C:G | W115C | 0.990 |
| 3:191268434:A:C | F114L | 0.983 |
| 3:191268434:A:T | F114L | 0.983 |
| 3:191268436:A:G | F114L | 0.983 |
| 3:191268429:T:A | K116I | 0.978 |
| 3:191268428:T:A | K116N | 0.968 |
| 3:191268428:T:G | K116N | 0.968 |
| 3:191268433:A:G | W115R | 0.966 |
| 3:191268433:A:T | W115R | 0.966 |
| 3:191268435:A:C | F114C | 0.964 |
| 3:191268427:A:G | Y117H | 0.963 |
| 3:191268429:T:G | K116T | 0.963 |
| 3:191268426:T:C | Y117C | 0.961 |
| 3:191268430:T:C | K116E | 0.950 |
| 3:191268420:A:T | V119D | 0.949 |
| 3:191268437:G:C | C113W | 0.948 |
| 3:191268439:A:G | C113R | 0.946 |
| 3:191268438:C:T | C113Y | 0.943 |
| 3:191268435:A:G | F114S | 0.938 |
| 3:191268423:C:T | C118Y | 0.937 |
| 3:191268424:A:G | C118R | 0.937 |
| 3:191268432:C:G | W115S | 0.933 |
| 3:191268422:A:C | C118W | 0.932 |
| 3:191268438:C:G | C113S | 0.930 |
| 3:191268439:A:T | C113S | 0.930 |
| 3:191268430:T:G | K116Q | 0.915 |
| 3:191268423:C:G | C118S | 0.912 |
| 3:191268424:A:T | C118S | 0.912 |
| 3:191268426:T:G | Y117S | 0.911 |
dbSNP variants (sampled 300 via entrez): RS1000041398 (3:191295220 C>T), RS1000068247 (3:191271913 A>C), RS1000071753 (3:191312853 A>C), RS1000091811 (3:191295503 T>C), RS1000131421 (3:191300254 T>C), RS1000143281 (3:191339032 C>G,T), RS1000255227 (3:191328910 A>C,G), RS1000262574 (3:191289364 G>A,T), RS1000265189 (3:191276334 C>A,G,T), RS1000282294 (3:191315834 T>C), RS1000300668 (3:191294191 G>T), RS1000305029 (3:191289147 C>T), RS1000356137 (3:191327617 A>C), RS1000362937 (3:191294633 A>T), RS1000363923 (3:191283634 G>T)
Disease associations
OMIM: gene MIM:618134 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000892_2 | Total ventricular volume (Alzheimer’s disease interaction) | 9.000000e-06 |
| GCST001951_1 | Alzheimer’s disease biomarkers | 5.000000e-09 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004760 | t-tau measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
11 total (human), top 11 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Aflatoxin B1 | decreases methylation, increases expression | 2 |
| bisphenol A | affects cotreatment, decreases methylation | 1 |
| 2,2’,4,4’,5-brominated diphenyl ether | increases expression | 1 |
| belinostat | decreases expression | 1 |
| abrine | increases expression | 1 |
| NSC 689534 | affects binding, decreases expression | 1 |
| Fulvestrant | affects cotreatment, decreases methylation | 1 |
| Copper | affects binding, decreases expression | 1 |
| Phenobarbital | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.